ALDH2 and oropharynx cancer: In Japan, HPV-negative oropharyngeal cancer patients with the ALDH2 heterozygous genotype had significantly poorer 3-year overall survival rate and disease-specific survival rate than the ALDH2 homozygous genotypes [55].